期刊文献+

急性缺血性心脑血管病病人血浆肾上腺髓质素与内皮素含量的测定 被引量:2

DETECTION OF PLASMA ADRENOMEDULLIN AND ENDOTHELIN IN PATIENTS WITH ACUTE ISCHEMIC CARDIOVASCULAR AND CEREBROVAS CULAR DISEASES
下载PDF
导出
摘要 ①目的 研究缺血性心脑血管病病人血浆肾上腺髓质素 (ADM)含量变化及其与血浆内皮素 (ET 1)的关系 ,探讨其在缺血性心脑血管病发生发展过程中的作用。②方法 应用放射免疫法 ,测定 4 0例急性脑梗死、4 0例急性心肌梗死病人和 4 5例正常人的血浆ADM和ET 1含量。③结果 脑梗死、心肌梗死组病人血浆ADM含量及ET 1含量均高于正常对照组 (F =37.5、2 2 .4 ,q =9.8~ 14 .6 ,P <0 .0 5 ) ;心肌梗死组、脑梗死组血浆ADM水平与血浆ET 1含量均呈显著正相关 (r =0 .5 74、0 .5 85 ,P <0 .0 1)。④结论 肾上腺髓质素参与了缺血性心脑血管病的发生发展过程。血浆ADM可作为判断脑梗死、心肌梗死血管内皮损伤程度的指标之一。 Objective\ To investigate the change of adren omedullin (ADM) in patients with acute ischemic cardiovascular and cerebrovascul ar diseases and its relationship with endothelin 1(ET 1) level . The role of t hem in the process of the disease was discussed. \ Methods\ Plasma concentration of ADM and ET 1 in patients with ac ute myocardial infarction(AMI, 40 cases), acute cerebral infarction(ACI, 40 case s) and 45 normal controls were measured by RIA.\ Results\ Plasma concentration of ADM and ET 1 in both AMI and ACI were significantly higher than that of the control ( F=37.5, 22.4; q=9.8-14.6 ;P <0.05), the ADM in AMI and ACI group showed a significantly positive c orrelation with the plasma concentration of ET 1 ( r=0.574,0.585;P < 0.01 ) .\ Conclusion\ These findings suggest that ADM might play an importan t role in the occurrence and development of AMI and ACI. The plasma ADM level ma y be used as a parameter reflecting the degree of endothelial injury.
出处 《青岛大学医学院学报》 CAS 2003年第4期436-438,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 急性缺血性心脑血管病 血浆 肾上腺髓质素 内皮素 临床意义 myocardial infarction cerebral infarction adre nomedullin endothelin 1
  • 相关文献

参考文献10

  • 1[1]Kitamura K,Kangawa K,Kawamoto M,et al.Adrenomedullin:a novel hypotensive peptide isolated from human pheochromocytoma[J]. Biochem Biophys Res Commun,1993,192(2):553.
  • 2[2]Sato K,Hirata Y,Imai T,et al.Characterization of immunoreactive adrenomedullin in human plasma and urine[J]. Life Sci,1995,57(2):189.
  • 3[3]Andreis PG,Tortorella C,Mazzocchi G,et al.Proadrenomedullin N-terminal 20 peptide inhibits adosterone secretion of human adrenocortical and Conn's adenoma cells:comparison with adrenomedullin effects[J]. J Clin Endocrinal Metab,1998,83(1):253.
  • 4[4]Kuwasako K,Kida O,Kitamura K,et al.Plasma adrenomedullin in cerebrovascular disease:a possible indicator of endothelial injury[J]. Int Angiol, 1997, 16(4):272.
  • 5[5]Takahashi K, Nakayama M, Totsune K, et al. Increased secretion of adrenomedullin from cultured human astrocytes by cytokines[J]. J Neurochem, 2000,74:99.
  • 6[6]Wang X,Yue TL,Barone FC,et al. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage[J]. Proc Natl Acad Sci USA, 1995, 92(25):11480.
  • 7[7]Jougasaki M,Rodeheffer RJ,Redfield MM,et al.Cardiac secretion of adrenomedullin in human heart failure[J]. J Clin Inves,1996,97:2370.
  • 8[8]Kobayashi K,Kitamura K,Etoh T,et al.Increased plasma adrenomedullin levels in chronic congestive heart failure[J]. Am Heart J,1996,131(5):994.
  • 9[9]Ishumi Y,Shoji H,Sugo S,et al.Regulation of adrenomedullin production in rat endothelial cells[J].Endocrinology,1998,139:838.
  • 10[10]Cormier-Regard S,Neuyen SV,Claycomb WC.Adrenmedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes[J]. J Biol Chem,1998,273:17787.

同被引文献38

  • 1Januzzi Jr. J.L.,PeacockW.F.,Maisel A.S.,黄欣.急性呼吸困难患者中白介素家族成员ST2的测定:PRIDE(急诊科呼吸困难患者脑利钠肽前体)研究的结果[J].世界核心医学期刊文摘(心脏病学分册),2007(12):54-55. 被引量:18
  • 2孙祎,陈玉国,张运.脑利钠肽的临床应用进展[J].心血管病学进展,2005,26(1):46-48. 被引量:14
  • 3崔玉英,唐朝枢.同型半胱氨酸在心血管疾病发病中的作用及其机制[J].临床内科杂志,2005,22(1):4-6. 被引量:28
  • 4刘梅颜.心血管检验的新进展[EB/OL].[2010-07-23].http://www.icirculation.com/article/article_detail.aspx?id=20000.
  • 5Rubins HB,Robins SJ,Collins D,et al.Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol.Veterans Afairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group[J].N Engl J Med,1999,341(6):410-418.
  • 6Kazi D,Farmer JA.Raising high-density lipoprotein cholesterol:innovative strategies against an old adversary[J].Curt Atheroseler Rep,2005,7(2):88-94.
  • 7Toth PP.Reverse cholesterol transport:high-density lipoprotein's magnificent mile[J].Curr Athereseler Rep,2003,5(5):386-391.
  • 8Walldius G,Jungner I,Aastveit AH,et al.The apoB/apoA-Ⅰ ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk[J].Clin Chem Lab Med,2004,42(12):1355-1363.
  • 9van der Steeg WA,Boekholdt SM,Stein EA,et al.Role of the apolipoprotein B-apolipoprotein A-Ⅰ ratio in cardiovascular risk assessment:a case-control analysis in EPIC-Norfolk[J].Ann Intern Med,2007,146(9):640-648.
  • 10Meisinger C,Loewel H,Mraz W,et al.Prognostic value of apolipoprotein B and A-Ⅰ in the prediction of myocardial infarction in middle-aged men and women:results from the MONICA/KORA Augsburg cohort study[J].Eur Heart J,2005,26(3):271-278.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部